GlassScriptPhysician profile
Norma L Perales
NPI 1457405953
$1,589.51
in general payments reported to CMS, 2019-2025
24 companies · $560 in 2025
The $560 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.67 · 2020: $89.40 · 2021: $27.50 · 2022: $154 · 2023: $302 · 2024: $420 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $276.16 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $133.01 | 2023-2025 | |
| Lilly USA, LLC | $130.12 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $126.36 | 2019-2025 | Octrode, Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $120.79 | 2023-2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $102.36 | 2022-2024 | Watchman Flx |
| Hologic Sales and Service, LLC | $80.32 | 2022-2024 | Aptima |
| Sanofi Pasteur INC. | $67.68 | 2019-2023 | |
| Topcon Healthcare Solutions, INC. | $63.43 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $57.32 | 2024-2025 | Airsupra |
| Astellas Pharma US INC | $53.17 | 2025 | Veozah |
| Seqirus USA INC | $52.93 | 2025 | Flucelvax, Fluad |
| Medtronic, INC. | $51.18 | 2021-2023 | Intellis Adaptivestim |
| Nevro Corp. | $49.08 | 2022-2024 | Senza |
| Sumitomo Pharma America, INC. | $40.07 | 2025 | Gemtesa |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $27.23 | 2025 | Auryon Laser System 100-120 Vac |
| Edwards Lifesciences Corporation | $25.97 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.68 | 2025 | Lifevest |
| Dexcom, INC. | $22.11 | 2025 | Dexcom G6 Transmitter |
| Amneal Pharmaceuticals LLC | $21.96 | 2024 | Unithroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.18 | 2025 | Jardiance |
| Currax Pharmaceuticals LLC | $16.10 | 2024 | Contrave |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.26 | 2025 | Xifaxan |
| Glaxosmithkline, LLC. | $13.04 | 2023 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norma Perales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.